Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2106/JBJS.22.00384 | DOI Listing |
J Prev Alzheimers Dis
January 2025
Alzheimer's Therapeutic Research Institute, University of Southern California, San Diego, CA, United States.
Background: Investigators conducting clinical trials have an ethical, scientific, and regulatory obligation to protect the safety of trial participants. Traditionally, safety monitoring includes manual review and coding of adverse event data by expert clinicians.
Objectives: Our study explores the use of natural language processing (NLP) and artificial intelligence (AI) methods to streamline and standardize clinician coding of adverse event data in Alzheimer's disease (AD) clinical trials.
J Cutan Pathol
January 2025
Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital/Mass General Brigham, Boston, Massachusetts, USA.
This brief overview is inspired by seminal contributions by the late Dr. Martin C. Mihm, Jr.
View Article and Find Full Text PDFNat Comput Sci
December 2024
École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Nat Methods
December 2024
GMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macao Joint Laboratory for Cell Fate Regulation and Diseases, Guangzhou National Laboratory, Guangzhou Medical University, Guangzhou, China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!